We are proud to share 2 reports published by Public Health England who have performed inactivation studies of our RNA stabilisation medium, virusPHIX™ and virusPHIX-LV™ on SARS-CoV-2 spiked samples.
Both reagents have shown inactivation of SARS-CoV-2 within 10 minutes at room temperature.
virusPHIX-LV™ is a sister product to virusPHIX™ developed to have a lower viscosity for optimal pipetting using automated robots used in the Lighthouse laboratories (Ortho, Hamilton & Tecan).
Read the full reports for both products here:
Our virusPHIX™ family of reagents inactivate SARS-CoV-2, making it safer to handle, transport and dispose of clinical samples – as well as preserving the viral RNA at room temperature to enable repeat testing if required. Not only that, virusPHIX™ is a guanidine-free product that contains no toxic materials. We have developed a number of virusPHIX™ reagents for different purposes, including a lower viscosity version for automated testing, and are currently validating another version for its compatibility with LAMP. Please get in touch if you would like to learn more by emailing us at email@example.com.